Journal of Cerebrovascular and Endovascular Neurosurgery

  • 제25권2호
  • /
  • Pages.143-149
  • /
  • 2023
  • /
  • 2234-8565(pISSN)
  • /
  • 2287-3139(eISSN)
대한뇌혈관외과학회 (Korean Society of Cerebravascular Surgeons)
권호 표지
DOI QR코드

DOI QR Code

Association between ischemic stroke and pyogenic spondylitis in Korea: Nationwide longitudinal cohort study

  • Soo Hyun Lee (Department of Neurosurgery, CHA University, CHA Bundang Medical Center) ;
  • Hakyung Kim (Genome & Health Big Data Branch, Department of Public Health, Graduate School of Public Health, Seoul National University) ;
  • In-bo Han (Department of Neurosurgery, CHA University, CHA Bundang Medical Center) ;
  • Seung Hun Sheen (Department of Neurosurgery, CHA University, CHA Bundang Medical Center) ;
  • Je Beom Hong (Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Seil Sohn (Department of Neurosurgery, CHA University, CHA Bundang Medical Center)
  • 투고 : 2022.09.06
  • 심사 : 2022.12.31
  • 발행 : 2023.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The purpose of this nationwide age- and sex- matched longitudinal study was to determine the pyogenic spondylitis (PS) increases the incidence of ischemic stroke (IS) in Korea. Methods: From the National Health Insurance Service (NHIS), we collected the patient data for the period from January 1, 2004 to December 31, 2015. PS was classified according to the International Classification of Disease codes M46.2-M46.8, M49.2, and M49.3. By using a 1:5 age- and sex- stratified matching, a total of 628 patients and 3140 control subjects were included in the study. The IS incidence rates in PS and control group was calculated by using the Kaplan-Meier method. The outcome of hazard ratio of IS was estimated by Cox proportional hazards regression analyses. This study did not exclude PS as a result of postoperative complications. Results: According to the study, 51 patients (8.12%) in the PS group and 201 patients (6.4%) in the control group experienced IS. The adjusted hazard ratio of IS in the PS group was 3.419 (95% CI: 2.473-4.729) after adjusting individual medical condition and demographics. Following the results of subgroup analysis, the risk ratio of IS was greater in most of the subgroup categories (male, female, age <65, age >65, non-diabetic, hypertensive, non-hypertensive, dyslipidemic and non-dyslipidemic subgroup). However, the risk of IS did not differ significantly in diabetic subgroup (95% CI: 0.953-4.360). Conclusions: The risk rate of IS increased in patient with pyogenic spondylitis.

키워드

과제정보

This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1I1A1A01072258). This work was also supported by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2020R1F1A1069875).

참고문헌

  1. Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017 Feb;120(3):502-13.
  2. Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke. 1996 Dec;27(12):2204-6.
  3. Cheung WY, Luk KDK. Pyogenic spondylitis. Int Orthop. 2012 Feb;36(2):397-404.
  4. Cowan LT, Alonso A, Pankow JS, Folsom AR, Rosamond WD, Gottesman RF, et al. Hospitalized infection as a trigger for acute ischemic stroke: the atherosclerosis risk in communities study. Stroke. 2016 Jun;47(6):1612-7.
  5. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001 Jan;32(1):133-8.
  6. Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond). 2005 Aug;109(2):171-6.
  7. Elkind MSV, Boehme AK, Smith CJ, Meisel A, Buckwalter MS. Infection as a stroke risk factor and determinant of outcome after stroke. Stroke. 2020;51(10):3156-68.
  8. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002 Dec;22(12):1399-419.
  9. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2355-63.
  10. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995 Mar;26(3):373-9.
  11. Handa K, Kono S, Saku K, Sasaki J, Kawano T, Sasaki Y, et al. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis. 1989 Jun;77(2-3):209-13.
  12. Ionita CC, Siddiqui AH, Levy EI, Hopkins LN, Snyder KV, Gibbons KJ. Acute ischemic stroke and infections. J Stroke Cerebrovasc Dis. 2011 Jan-Feb;20(1):1-9.
  13. Jeong DK, Lee HW, Kwon YM. Clinical value of procalcitonin in patients with spinal infection. J Korean Neurosurg Soc. 2015 Sep;58(3):271-5.
  14. Jeong SJ, Choi SW, Youm JY, Kim HW, Ha HG, Yi JS. Microbiology and epidemiology of infectious spinal disease. J Korean Neurosurg Soc. 2014 Jul;56(1):21-7.
  15. Kim YJ, Hong JB, Kim YS, Yi J, Choi JM, Sohn S. Change of pyogenic and tuberculous spondylitis between 2007 and 2016 year: a nationwide study. J Korean Neurosurg Soc. 2020 Nov;63(6):784-93.
  16. Kim YS, Kim JG, Yi J, Choi JM, Chung CK, Choi UY, et al. Changes in the medical burden of pyogenic and tuberculous spondylitis between 2007 and 2016: a nationwide cohort study. J Clin Neurosci. 2020 Mar;73:89-93.
  17. Lee DH, Choi YJ, Han IB, Hong JB, Han KD, Choi JM, et al. Association of ischemic stroke with ankylosing spondylitis: a nationwide longitudinal cohort study. Acta Neurochir (Wien). 2018 May;160(5):949-55.
  18. Lee DH, Sheen SH, Lee DG, Jang JW, Lee DC, Shin SH, et al. Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: a nationwide longitudinal cohort study. PloS One. 2021 May;16(5):e0251851.
  19. Lee JK, Kim H, Hong JB, Sheen SH, Han IB, Sohn S. Association of acute myocardial infarction with seropositive rheumatoid arthritis in Korea: a nationwide longitudinal cohort study. J Clin Neurosci. 2020 Aug;78:97-101.
  20. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1263-8.
  21. McColl B, Allan SM, Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 2009 Feb;158(3):1049-61.
  22. Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, et al. Association between infectious burden, socioeconomic status, and ischemic stroke. Atherosclerosis. 2016 Nov;254:117-23.
  23. Park CJ, Choi YJ, Kim JG, Han IB, Han KD, Choi JM, et al. Association of acute myocardial infarction with ankylosing spondylitis: a nationwide longitudinal cohort study. J Clin Neurosci. 2018 Oct;56:34-7.
  24. Rodriguez-Yanez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol. 2008 Jun;21(3):353-7.
  25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 Jan;340(2):115-26.
  26. Sato K, Yamada K, Yokosuka K, Yoshida T, Goto M, Matsubara T, et al. Pyogenic spondylitis: clinical features, diagnosis and treatment. Kurume Med J. 2019 Sep 25;65(3):83-9.
  27. Sebastian S, Stein LK, Dhamoon MS. Infection as a stroke trigger: associations between different organ system infection admissions and stroke subtypes. Stroke. 2019 Aug;50(8):2216-8.
  28. Shao IY, Elkind MS, Boehme AK. Risk factors for stroke in patients with sepsis and bloodstream infections. Stroke. 2019 May;50(5):1046-51.
  29. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006 Jul;37(7):1923-32.
  30. Stone M, Thorp J. Plasma fibrinogen-a major coronary risk factor. J R Coll Gen Pract. 1985 Dec;35(281):565-9.